SCOPUS 정보 검색 플랫폼

Volumn 162, Issue 10, 2002, Pages 1091-1092

Selective COX-2 inhibitors, NSAIDS, aspirin, and myocardial infarction

a NONE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

EDITORIAL; ENZYME INHIBITION; HEART INFARCTION; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0037182025 PISSN: 00039926 EISSN: None Source Type: Journal
DOI: 10.1001/archinte.162.10.1091 Document Type: Editorial

Times cited : (49)

References (13)

1
- 0034707105
- Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
- (2000) N Engl J Med , vol.343 , pp. 1520-1528
- Bombardier, C.¹ Laine, L.² Reicin, A.³

2
- 0035934070
- Risk of cardiovascular events associated with selective COX-2 inhibitors
- (2001) JAMA , vol.286 , pp. 954-959
- Mukherjee, D.¹ Nissen, S.E.² Topol, E.J.³

3
- 0034644396
- Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial
- (2000) JAMA , vol.284 , pp. 1247-1255
- Silverstein, F.E.¹ Faich, G.² Goldstein, J.L.³

4
- 0034763373
- Aspirin for primary prevention of coronary heart disease: Safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
- (2001) Heart , vol.85 , pp. 265-271
- Sanmuganathan, P.S.¹ Ghahramani, P.² Jackson, P.R.³ Wallis, E.J.⁴ Ramsay, L.E.⁵

5
- 0035818601
- Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib
- (2001) Circulation , vol.104 , pp. 2280-2288
- Konstam, M.A.¹ Weir, M.R.² Reicin, A.³

6
- 0028120906
- Collaborative overview of randomized trials of antiplatelet therapy, I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
- (1994) BMJ , vol.308 , pp. 81-86

7
- 0037182013
- Nonsteroidal anti-inflammatory drug use and acute myocardial infarction
- (2002) Arch Intern Med , vol.162 , pp. 1099-1104
- Solomon, D.H.¹ Grynn, R.J.² Levin, R.³ Avorn, J.⁴

8
- 0037182008
- Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis
- (2002) Arch Intern Med , vol.162 , pp. 1105-1110
- Watson, D.J.¹ Rhodes, T.² Cai, B.³ Guess, H.A.⁴

9
- 0037182023
- Association between naproxen use and protection against acute myocardial infarction
- (2002) Arch Intern Med , vol.162 , pp. 1111-1115
- Rahme, E.¹ Pilote, L.² LeLorier, J.³

10
- 0033673612
- Comparative activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers
- (2000) J Clin Pharmacol , vol.40 , pp. 1109-1120
- VanHecken, A.¹ Schwartz, J.I.² Depre, M.³

11
- 0035125570
- Antithombotic agents in coronary artery disease
- (2001) Chest , vol.119
- Cairns, J.A.¹ Theroux, P.² Lewis, D.L.³

12
- 0025831584
- An apple a day or an aspirin a day?
- (1991) Arch Intern Med , vol.151 , pp. 1066-1069
- Dalen, J.E.¹

13
- 0034645456
- An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease
- (2000) Arch Intern Med , vol.160 , pp. 3123-3127
- Hebert, P.R.¹ Hennekens, C.H.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.